Close Menu

executive appointment

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Cartagenia has opened its first North American office in Boston, the Leuven, Belgium-based bioinformatics firm said today.

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – On-Q-ity today announced it has raised $5 million in financing and it has appointed Michael Stocum as the company's president and CEO.

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Applied Proteomics said today that it has reeled in $22.5 million in a Series B financing, has moved its corporate headquarters to San Diego, and has named Peter Klemm to be its CEO.

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Pacific Biosciences today announced Michael Hunkapiller is replacing Hugh Martin as the company's president and CEO, effective immediately.

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Horizon Discovery today said that it has raised £11.3 million ($18.6 million) in a Series C round of financing.

Forlenza has been at BD for more than three decades and succeeds Edward Ludwig as CEO in accordance with the company's long-term succession planning that began in 2008.

President and CEO J. Robert Hurley is now also interim Diagnostic Division President, while Scott Atkins was named president of the Life Science Division.

Shares of the company climbed as much as 13 percent, and in an analyst note, R.W. Baird said incoming CEO Frank Witney could return Affymetrix to top-line growth.

Pages

A New Zealand minister says the country's genetic modification laws need to be re-examined to help combat climate change, the New Zealand Herald reports.

A new analysis finds some cancers receive more nonprofit dollars than others.

An Australian mother's conviction in the deaths of her children may be re-examined after finding that two of the children carried a cardiac arrhythmia-linked gene variant.

In Science this week: comparative analysis of sex differences in mammal gene expression, and more.